Johnson & Johnson (JNJ) Return on Equity [ROE] (2009 - 2026)
Johnson & Johnson (JNJ) reported Return on Equity [ROE] of 25.32% for Q2 2026, down 3.62 percentage points from 28.94% a year earlier and down 0.54 percentage points from the prior quarter.
Powered by 
Analysis
Johnson & Johnson (JNJ) Return on Equity [ROE] (2009 - 2026) Analysis & Trends
For FY2025, Johnson & Johnson posted Return on Equity [ROE] of 35.03%, up 14.97 percentage points from FY2024.
- Return on Equity [ROE] has a four-year change of +11.06 percentage points (FY2021 to FY2025).
- By year, Return on Equity [ROE] came in at 20.06% in FY2024 (-28.24 pp), 48.29% in FY2023 (+24.50 pp), 23.79% in FY2022 and 23.97% in FY2021.
- The Q2 2026 figure ranks as the lowest quarterly Return on Equity [ROE] since Q4 2024.
- Year over year, Return on Equity [ROE] gained in two of the last eight quarters, with an average year-over-year change of -11.24 percentage points.
- The high point for year-over-year Return on Equity [ROE] in five years was Q1 2024 (a gain of 38.21 percentage points); the low point was Q4 2024 (a drop of 30.36 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at 25.86% (Q1 2026), 33.33% (Q4 2025) and 31.85% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn | - |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn | 22.24% |
| 10 | Bristol Myers Squibb | 128.45 Bn | 79.72 Bn | 9.25 Bn | 43.72% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 28, 2026 | 25.32% |
| Mar 29, 2026 | 25.86% |
| Dec 28, 2025 | 33.33% |
| Sep 28, 2025 | 31.85% |
| Jun 29, 2025 | 28.94% |
| Mar 30, 2025 | 29.16% |
| Dec 29, 2024 | 19.86% |
| Sep 29, 2024 | 20.73% |
| Jun 30, 2024 | 53.71% |
| Mar 31, 2024 | 55.44% |
| Dec 31, 2023 | 50.22% |
| Oct 1, 2023 | 46.90% |
| Jul 2, 2023 | 17.73% |
| Apr 2, 2023 | 17.23% |
| Jan 1, 2023 | 23.70% |
| Oct 2, 2022 | 23.96% |
| Jul 3, 2022 | 26.36% |
| Apr 3, 2022 | 28.63% |
| Oct 3, 2021 | 25.57% |
| Jul 4, 2021 | 26.24% |
API Access
Johnson & Johnson Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=JNJ&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "JNJ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=JNJ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();